---
document_datetime: 2024-07-22 10:54:08
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/luveris-epar-all-authorised-presentations_en.pdf
document_name: luveris-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.92233
conversion_datetime: 2025-12-29 22:09:21.07581
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number (Invented) name   | Strength   | Pharmaceutical Form                           | Route of administration   | Immediate Packaging                         | Content (concentration)                 | Pack size           |
|----------------------------------|------------|-----------------------------------------------|---------------------------|---------------------------------------------|-----------------------------------------|---------------------|
| EU/1/00/155/004 Luveris          | 75 IU      | Powder and solvent for solution for injection | Subcutaneous use          | powder: vial (glass); solvent: vial (glass) | powder: 75 IU; solvent: 1 ml (75 IU/ml) | 1 vial + 1 vial     |
| EU/1/00/155/005 Luveris          | 75 IU      | Powder and solvent for solution for injection | Subcutaneous use          | powder: vial (glass); solvent: vial (glass) | powder: 75 IU; solvent: 1 ml (75 IU/ml) | 3 vials + 3 vials   |
| EU/1/00/155/006 Luveris          | 75 IU      | Powder and solvent for solution for injection | Subcutaneous use          | powder: vial (glass); solvent: vial (glass) | powder: 75 IU; solvent: 1 ml (75 IU/ml) | 10 vials + 10 vials |